SEC Form 8-K Summary
Registrant: Safety Shot, Inc. (the filing text does not identify BONK, Inc. as the registrant)
Reporting date: April 22, 2024; filed and signed April 26, 2024. The filing reports entry into a material employment agreement and related stock option award.
Business Context and Reporting Period
Safety Shot, Inc., a Delaware corporation headquartered in Jupiter, Florida, is listed on Nasdaq under the symbols SHOT and SHOTW. The company identifies itself as an emerging growth company. This Form 8-K does not provide quarterly or annual operating results.
Financial and Compensation Matters
- Employment compensation: Danielle De Rosa is entitled to annual compensation of $250,000, payable twice monthly.
- Stock options: Ms. De Rosa received an option to purchase 200,000 shares of common stock at an exercise price of $1.57 per share.
- Option term: The options expire five years after issuance and are subject to the related option agreement.
- Revenue, profit, cash flow, margins, debt, and liquidity: The filing text does not provide clear values or discussion for these items.
Material Changes Versus the Prior Comparable Period
The filing does not present comparative financial information. The material reported change is the appointment or engagement of Danielle De Rosa under a new employment agreement, together with the related stock option award.
Guidance, Outlook, Risks, and Unusual Items
- The filing provides no financial guidance, operating outlook, or management forecast.
- The agreement creates an annual cash compensation obligation of $250,000 and potential equity dilution from options covering 200,000 shares.
- The filing text does not state the vesting schedule or other detailed terms of the options; investors should review the complete Option Agreement.
- The complete Employment Agreement and Option Agreement were filed as Exhibits 10.1 and 10.2.
Important Facts to Verify
- Confirm the correct issuer, because the request metadata names BONK, Inc., while the filing identifies Safety Shot, Inc.
- Review Exhibits 10.1 and 10.2 for the full employment, termination, incentive, vesting, and option provisions.
- Verify the option issuance date, vesting schedule, share availability, and potential dilution.
- Confirm whether any additional executive appointment or reporting implications apply beyond the information incorporated from Item 1.01 into Item 5.02.